Fresenius SE & Co. (OTCMKTS:FSNUY) Sees Unusually-High Trading Volume – Still a Buy?

Posted by Kyle Jackson on Jul 19th, 2026

Shares of Fresenius SE & Co. (OTCMKTS:FSNUY – Get Free Report) saw unusually-strong trading volume on Friday . Approximately 351,670 shares traded hands during mid-day trading, an increase of 151% from the previous session’s volume of 140,259 shares.The stock last traded at $12.0870 and had previously closed at $12.07.

Analyst Ratings Changes

Separately, Morgan Stanley reaffirmed an “overweight” rating on shares of Fresenius SE & Co. in a research note on Tuesday, June 23rd. Three investment analysts have rated the stock with a Buy rating, Based on data from MarketBeat, the company presently has a consensus rating of “Buy”.

View Our Latest Report on Fresenius SE & Co.

Fresenius SE & Co. Stock Down 0.7%

The firm’s 50-day simple moving average is $11.42 and its 200 day simple moving average is $12.93. The company has a debt-to-equity ratio of 0.41, a quick ratio of 0.98 and a current ratio of 1.27. The stock has a market capitalization of $27.01 billion, a P/E ratio of 15.99 and a beta of 0.63.

Fresenius SE & Co. (OTCMKTS:FSNUY – Get Free Report) last posted its quarterly earnings data on Wednesday, May 6th. The company reported $0.24 EPS for the quarter, missing analysts’ consensus estimates of $0.25 by ($0.01). The business had revenue of $6.75 billion for the quarter, compared to analyst estimates of $6.79 billion. Fresenius SE & Co. had a return on equity of 10.09% and a net margin of 6.55%. As a group, research analysts expect that Fresenius SE & Co. will post 1.03 EPS for the current year.

Fresenius SE & Co. Company Profile

(Get Free Report)

Fresenius SE & Co KGaA is a global healthcare group headquartered in Bad Homburg vor der Höhe, Germany. Founded in 1912 by Eduard Fresenius, the company has grown into one of the world’s leading providers of products and services for dialysis, hospitals and outpatient medical care. Trading on major European exchanges and available over the counter in the U.S. as FSNUY, Fresenius SE & Co brings together a portfolio of specialized healthcare businesses under one corporate umbrella.

The company operates through four main business segments.